{"id":"NCT00602472","sponsor":"Boehringer Ingelheim","briefTitle":"BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes","officialTitle":"A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg) Administered Orally Once Daily Over 24 Weeks, With an Open-label Extension to One Year (Placebo Patients Switched to BI 1356), in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite a Therapy of Metformin in Combination With a Sulphonylurea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2009-05","completion":null,"firstPosted":"2008-01-28","resultsPosted":"2011-06-15","lastUpdate":"2014-03-28"},"enrollment":1058,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"linagliptin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"linagliptin 5 mg","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of the current study is to investigate the efficacy, safety and tolerability of BI 1356 (5 mg once daily) compared to placebo given for 24 weeks as add-on therapy to metformin in combination with a sulphonylurea in patients with type 2 diabetes mellitus with insufficient glycaemic control.","primaryOutcome":{"measure":"HbA1c Change From Baseline to Week 24","timeFrame":"Baseline and week 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.1,"sd":0.05},{"arm":"Linagliptin","deltaMin":-0.72,"sd":0.03}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":100,"countries":["Argentina","Belgium","Canada","China","Germany","Philippines","Russia","South Korea","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["27484756","23672632","22234149","21781152"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10,"n":263},"commonTop":["Hypoglycaemia","Upper respiratory tract infection","Hyperglycaemia","Nasopharyngitis","Urinary tract infection"]}}